Treatment Outcomes in Infections Caused by "SPICE" (Serratia, Pseudomonas, Indole-positive Proteus, Citrobacter, and Enterobacter) Organisms: Carbapenem versus Noncarbapenem Regimens.

Citation data:

Clinical therapeutics, ISSN: 1879-114X, Vol: 39, Issue: 1, Page: 170-176

Publication Year:
2017
Usage 44
Abstract Views 37
Link-outs 7
Captures 18
Readers 17
Exports-Saves 1
Social Media 13
Tweets 13
Citations 2
Citation Indexes 2
Repository URL:
https://touroscholar.touro.edu/tcopny_pubs/123; http://www.sciencedirect.com/science/article/pii/S0149291816309006
PMID:
28034519
DOI:
10.1016/j.clinthera.2016.11.025
Author(s):
Moy, Stanley; Sharma, Roopali
Publisher(s):
Elsevier BV; Touro Scholar
Tags:
Pharmacology, Toxicology and Pharmaceutics; Medicine; AmpC β-lactamase; bacteremia; carbapenem; urinary tract infection; Pharmacy and Pharmaceutical Sciences
Most Recent Tweet View All Tweets
article description
Techniques used to identify AmpC β-lactamases in SPICE (Serratia, Pseudomonas, indole-positive Proteus, Citrobacter, and Enterobacter) organisms are not yet optimized for the clinical laboratory and are not routinely used. Clinicians are often left with an uncertainty on the choice of antibiotic when a SPICE organism is isolated. The purpose of this study was to evaluate the outcomes of carbapenem versus noncarbapenem regimens in treating bacteremia or urinary tract infection from a SPICE organism in clinical practice.